Disc Medicine
Disc Medicine Inc is a clinical-stage biopharmaceutical enterprise headquartered in Watertown, Massachusetts. The company specializes in the discovery, development, and commercialization of novel therapeutic medicines addressing severe hematologic diseases and blood disorders. Its proprietary research and clinical pipeline focuses on treating patients suffering from rare conditions including erythropoietic protoporphyria, myelodysplastic syndromes, and related anemias. Principal revenue is currently generated through research grants, biopharmaceutical collaboration agreements, and strategic development partnerships. The enterprise serves medical researchers, hematology specialists, and clinical patient networks. Disc Medicine Inc is publicly traded on the Nasdaq Stock Market.
5 of the funds FundTelligence covers report a position in Disc Medicine.
- Legal name
- Disc Medicine Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 5
Funds holding Disc Medicine
- JPM US Small Cap Growth Fund — JPM · 0.79 % (full portfolio disclosed, June 2026)
- Schroder ISF Healthcare Innovation — Schroders · 0.61 % (full portfolio disclosed, June 2026)
- JPM Global Healthcare Fund — JPM · 0.49 % (full portfolio disclosed, June 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.2 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)